ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 168516 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 168516; 2) Community: the network communities that were significantly associated with the response to NSC 168516; 3) Molecule: the relationships between components within communities and NSC 168516; 4) MDR: the compounds that were significantly associated with the NSC 168516.

NSC Compound Enrichment Correlation
NSC 671870 - 0.0119221520283057 0.44742072
NSC 673191 Null 0.0119221520283057 0.43677234
NSC 677768 Null 0.0119221520283057 0.059726956
NSC 683664 2-Azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaene- 3,20,22-trione, 9-[[(amino)carbonyl]oxy]-8,14-dimethoxy- 4,10,12,16-tetramethyl-13-[3-(dimethylamino)- 1-oxopropoxy)-19-[(2-propenyl)amino]-,stere 0.0119221520283057 0.42322927
NSC 685988 Dihydroartemisinyl ether, stereoisomer of NSC-685989 0.0119221520283057 0.30039932
NSC 691520 Null 0.0119221520283057 0.24042459
NSC 698395 Morpholine, 4,4'-(3,4-dichloro-2,4-dinitro-1,3-butadiene- 1,1-diyl)bis-, (1E,3E)- 0.0119221520283057 0.18328786
NSC 699756 Null 0.0119221520283057 0.34347552
NSC 724040 Null 0.0119221520283057 0.61589486
NSC 726194 2-ethyl 3-[(6-ethyl, 4-amino, 5-(4-chlorophenyl) pyrimidin-2-yl)] quinazolin-4-one 0.0119221520283057 0.088947452
Total:118  Current:43    [First] [Prev] [Next] [Last]